407 related articles for article (PubMed ID: 30986689)
21. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
[TBL] [Abstract][Full Text] [Related]
22. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
23. Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
Kumar A; Thotakura PL; Tiwary BK; Krishna R
BMC Microbiol; 2016 May; 16():84. PubMed ID: 27176600
[TBL] [Abstract][Full Text] [Related]
24.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
25. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15.
Zhu H; Li M; Bi D; Yang H; Gao Y; Song F; Zheng J; Xie R; Zhang Y; Liu H; Yan X; Kong C; Zhu Y; Xu Q; Wei Q; Qin H
Nat Commun; 2024 Feb; 15(1):1688. PubMed ID: 38402201
[TBL] [Abstract][Full Text] [Related]
26. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated
Lamprinaki D; Garcia-Vello P; Marchetti R; Hellmich C; McCord KA; Bowles KM; Macauley MS; Silipo A; De Castro C; Crocker PR; Juge N
Front Immunol; 2021; 12():744184. PubMed ID: 34659241
[No Abstract] [Full Text] [Related]
27. Immunogenicity of a Fap2 peptide mimotope of
Guevarra LA; Afable ACF; Belza PJO; Dy KJS; Lee SJQ; Sy-Ortin TT; Albano PMSP
Infect Agent Cancer; 2018; 13():11. PubMed ID: 29619076
[TBL] [Abstract][Full Text] [Related]
28. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
Chen L; Zhao R; Kang Z; Cao Z; Liu N; Shen J; Wang C; Pan F; Zhou X; Liu Z; Yang Y; Chen Q
J Control Release; 2023 Nov; 363():43-56. PubMed ID: 37734673
[TBL] [Abstract][Full Text] [Related]
29.
Zhang Y; Zhang L; Zheng S; Li M; Xu C; Jia D; Qi Y; Hou T; Wang L; Wang B; Li A; Chen S; Si J; Zhuo W
Gut Microbes; 2022; 14(1):2038852. PubMed ID: 35220887
[TBL] [Abstract][Full Text] [Related]
30. Utilizing Whole
Umaña A; Sanders BE; Yoo CC; Casasanta MA; Udayasuryan B; Verbridge SS; Slade DJ
J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501282
[No Abstract] [Full Text] [Related]
31. Impact of
Kim YJ; Kim BK; Park SJ; Kim JH
World J Gastroenterol; 2021 Aug; 27(29):4879-4889. PubMed ID: 34447232
[TBL] [Abstract][Full Text] [Related]
32. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
Rev Gastroenterol Mex (Engl Ed); 2021 Jun; ():. PubMed ID: 34210555
[TBL] [Abstract][Full Text] [Related]
33. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
34.
Wang S; Liu Y; Li J; Zhao L; Yan W; Lin B; Guo X; Wei Y
Front Cell Dev Biol; 2021; 9():710165. PubMed ID: 34490259
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression.
Parhi L; Alon-Maimon T; Sol A; Nejman D; Shhadeh A; Fainsod-Levi T; Yajuk O; Isaacson B; Abed J; Maalouf N; Nissan A; Sandbank J; Yehuda-Shnaidman E; Ponath F; Vogel J; Mandelboim O; Granot Z; Straussman R; Bachrach G
Nat Commun; 2020 Jun; 11(1):3259. PubMed ID: 32591509
[TBL] [Abstract][Full Text] [Related]
36. Cell Surface Fibroblast Activation Protein-2 (Fap2) of
Padma S; Patra R; Sen Gupta PS; Panda SK; Rana MK; Mukherjee S
Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992108
[TBL] [Abstract][Full Text] [Related]
37. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Gur C; Ibrahim Y; Isaacson B; Yamin R; Abed J; Gamliel M; Enk J; Bar-On Y; Stanietsky-Kaynan N; Coppenhagen-Glazer S; Shussman N; Almogy G; Cuapio A; Hofer E; Mevorach D; Tabib A; Ortenberg R; Markel G; Miklić K; Jonjic S; Brennan CA; Garrett WS; Bachrach G; Mandelboim O
Immunity; 2015 Feb; 42(2):344-355. PubMed ID: 25680274
[TBL] [Abstract][Full Text] [Related]
38. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.
Yu T; Guo F; Yu Y; Sun T; Ma D; Han J; Qian Y; Kryczek I; Sun D; Nagarsheth N; Chen Y; Chen H; Hong J; Zou W; Fang JY
Cell; 2017 Jul; 170(3):548-563.e16. PubMed ID: 28753429
[TBL] [Abstract][Full Text] [Related]
39.
Yang Z; Ji G
Oncol Lett; 2019 Aug; 18(2):975-982. PubMed ID: 31423156
[TBL] [Abstract][Full Text] [Related]
40. Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity.
Meng Q; Gao Q; Mehrazarin S; Tangwanichgapong K; Wang Y; Huang Y; Pan Y; Robinson S; Liu Z; Zangiabadi A; Lux R; Papapanou PN; Guo XE; Wang H; Berchowitz LE; Han YW
EMBO Rep; 2021 Jul; 22(7):e52891. PubMed ID: 34184813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
